News
-
-
PRESS RELEASE
Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually -
PRESS RELEASE
Tryp Therapeutics Obtains Interim Order for Plan of Arrangement and Provides Details of Shareholder Meeting
Tryp Therapeutics, Inc. obtains interim court order for proposed arrangement with Exopharm Limited ACN 163 765 991. Meeting scheduled for March 8, 2024, in Toronto, Ontario, to vote on the arrangement resolution -
-
PRESS RELEASE
Temas Resources Announces Non-Brokered Private Placement of up to $1.5 Million
Temas Resources Corp. announces non-brokered private placement of up to 6,000,000 units at a price of $0.25 per share for gross proceeds of $1.5 million. The Company intends to use proceeds for advancing the La Blache project, marketing, and working capital -
PRESS RELEASE
Vulcan Minerals Inc. - Red Cross Lake Delivers Stellar Nickel-Copper-Cobalt Soil Anomaly in Newfoundland
Vulcan Minerals Inc. announces impressive soil geochemical results from the Red Cross Lake Nickel-Copper-Cobalt Project in central Newfoundland, confirming significant potential for magmatic style mineralization in a favourable geologic environment, initiating permitting for advanced exploration including drilling in 2024 -
PRESS RELEASE
Specificity Strengthens Client Services with the Appointment of Account Management Expert Shelby DeCarlo
Specificity Inc. (OTCQB:SPTY) announces Shelby DeCarlo as Client Success Manager, enhancing client support and retention. CEO Jason Wood expresses confidence in Shelby's ability to drive client success and contribute to the company's growth -
PRESS RELEASE
Sparta Capital Announces Issuing of Management Cease Trade Order
Sparta Group (TSXV:SAY) provides an update on the Management Cease Trade Order received from the Alberta Securities Commission due to the delay in filing its annual financial statements. The Company expects to file the Annual Filings by March 29, 2024, while regular trading continues unaffected. The new management team assures business as usual during this period -
-
